Selection of TcII Trypanosoma cruzi population following macrophage infection

Journal of Infectious Diseases

Volumn 204, Issue 3, 2011, Pages 478-486

  Pena, Darlene A ^a   Eger, Iriane ^a,b   Nogueira, Lucas ^a   Heck, Nicoli ^a   Menin, Álvaro ^a   Báfica, André ^a   Steindel, Mário ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^b UNIVERSIDADE DO VALE DO ITAJAÍ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN G ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHAGAS DISEASE; CONTROLLED STUDY; GROWTH INHIBITION; HOST PARASITE INTERACTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE; MOUSE; NONHUMAN; OPSONIZATION; PERITONEUM CELL; PRIORITY JOURNAL; TRIATOMA; TRIATOMA TIBIAMACULATA; TRYPANOSOMA CRUZI; TRYPANOSOMA RANGELI; TRYPOMASTIGOTE;

ACUTE DISEASE; ANIMALS; ANTIBODIES, PROTOZOAN; CHAGAS DISEASE; HUMANS; INTERFERON-GAMMA; MACROPHAGE ACTIVATION; MACROPHAGES; MALE; MICE; MICE, INBRED BALB C; PHYLOGENY; TRYPANOSOMA CRUZI;

EID: 79960127261     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir292     Document Type: Article

References (44)

1. Teixeira AR, Nitz N, Guimaro MC, Gomes C, Santos-Buch CA. Chagas disease. Postgrad Med J 2006; 82:788-98. (Pubitemid 46101925)
2. Moncayo A. Chagas disease: current epidemiological trends after the interruption of vectorial and transfusional transmission in the Southern Cone countries. Mem Inst Oswaldo Cruz 2003; 95:577-91. (Pubitemid 38019577)
3. Macedo AM, Machado CR, Oliveira RP, Pena SD. Trypanosoma cruzi: genetic structure of populations and relevance of genetic variability to the pathogenesis of Chagas disease. Mem Inst Oswaldo Cruz 2004; 99:1-11.
4. Fernandes O, Santos SS, Cupolillo E, et al. A mini-exon multiplex polymerase chain reaction to distinguish the major groups of Trypanosoma cruzi and T. rangeli in the Brazilian Amazon. Trans R Soc Trop Med Hyg 2001; 95:97-9. (Pubitemid 34202239)
5. Souto RP, Fernandes O, Macedo AM, Campbell DA, Zingales B. DNA markers define two major phylogenetic lineages of Trypanosoma cruzi. Mol Biochem Parasitol 1996; 3:141-52. (Pubitemid 27062386)
6. Anonymous. Recommendations from a satellite meeting. Mem Inst Oswaldo Cruz 1999; 94:429-32.
7. Zingales B, Andrade SG, Briones MR, et al. A new consensus for Trypanosoma cruzi intraspecific nomenclature: second revision meeting recommends TcI to TcVI. Mem Inst Oswaldo Cruz 2009; 104:1051-4.
8. Di Noia JM, Buscaglia CA, De Marchi CR, Almeida IC, Frasch AC. A Trypanosoma cruzi small surface molecule provides the first immunological evidence that Chagas disease is due to a single parasite lineage. J Exp Med 2002; 195:401-13. (Pubitemid 34461294)
9. Freitas JM, Lages-Silva E, Crema E, Pena SD, Macedo AM. Real time PCR strategy for the identification of major lineages of Trypanosoma cruzi directly in chronically infected human tissues. Int J Parasitol 2005; 35:411-7. (Pubitemid 40381159)
10. Gomes ML, Macedo AM, Vago AR, Pena SD, Galvão LM, Chiari E. Trypanosoma cruzi: optimization of polymerase chain reaction for detection in human blood. Exp Parasitol 1998; 88:28-33. (Pubitemid 28375811)
11. 2+ in the process of cell invasion by intracellular parasites. Parasitol Today 1996; 2:61-5.
12. Burleigh B, Andrews NW. Signaling and host cell invasion by Trypanosoma cruzi. Curr Opin Microbiol 1998; 1:461-5. (Pubitemid 128423263)
13. Yoshida N. Molecular basis of mammalian cell invasion by Trypanosoma cruzi. Acad Bras Cienc 2006; 78:87-111.
14. Ruiz RC, Favoreto S, Dorta ML, et al. Infectivity of Trypanosoma cruzi stains is associated with differential expression of surface glycoproteins with differential Ca21 signaling activity. Biochem J 1998; 330:505-11.
15. Ferreira V, Valck C, Sánchez GA, et al. The classical activation pathway of the human complement system is specifically inhibited by calreticulin from Trypanosoma cruzi. J Immunol 2004; 172:3042-50. (Pubitemid 38263693)
16. Tarleton RL. Immune system recognition of Trypanosoma cruzi. Curr Opin Immunol 2007; 19:430-4. (Pubitemid 47284855)
17. Brener Z, Gazzinelli RT. Immunological control of Trypanosoma cruzi infection and pathogenesis of Chagas' disease. Int Arch Allergy Immunol 1997; 114:103-10. (Pubitemid 27397063)
18. Gazzinelli RT, Denkers EY. Protozoan encounters with Toll-like receptor signalling pathways: implications for host parasitism. Nat Rev Immunol 2006; 6:895-906. (Pubitemid 44851732)
19. Gazzinelli RT, Oswald IP, Hieny S, James SL, Sher A. The microbicidal activity of interferon-γ-treated macrophages against Trypanosoma cruzi involves an L-arginine-dependent, nitrogen oxide-mediated mechanism inhibitable by interleukin-10 and transforming growth factor-β. Eur J Immunol 1992; 22:2501-6.
20. Schroder K, Hertzog PJ, Ravasi T, Hum DA. Interferon-γ: an overview of signals, mechanisms and functions. J Leukoc Biol 2004; 75:163-89. (Pubitemid 38174573)
21. Steindel M, Pacheco LK, Scholl D, et al. Characterization of Trypanosoma cruzi isolated from humans, vectors, and animal reservoirs following an outbreak of acute human Chagas disease in Santa Catarina State, Brazil. Diagn Microbiol Infect Dis 2008; 60:25-32. (Pubitemid 350235169)
22. Bafica A, Scanga CA, Feng C, Leifer C, Cheever AW, Sher A. TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis. J ExpMed 2005; 202:1715-24. (Pubitemid 41815877)
23. Weyenbergh JV, Silva M, Bafica A, Cardoso S, Wietzerbin J, Barral-Netto M. IFN-beta and TGF-beta differentially regulate IL-12 activity in human peripheral blood mononuclear cells. Immunol Lett 2001; 75:117-22.
24. Steindel M, Dias Neto E, Menezes CL, Romanha AJ, Simpson AJ. Random amplified polymorphic DNA analysis of Trypanosoma cruzi strains. Mol Biochem Parasitol 1993; 60:71-80. (Pubitemid 23201987)
25. Lee YK, Chang HH, Kim JS, Kim JK, Lee KS. Lignocellulolytic mutants of Pleurotus ostreatus induced by gamma-ray radiation and their genetic similarities. Radiat Phys Chem 2000; 57:145-50.
26. Brisse S, Verhoef J, Tibayrenc M. Characterization of large and small subunit rRNA and mini-exon genes further supports the distinction of six Trypanosoma cruzi lineages. Int J Parasitol 2001; 31:1218-26. (Pubitemid 32762992)
27. Green LC, Wagner DA, Glogowski J, Skipper PL, Whishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite and (15N) nitrate in biological fluids. Anal Biochem 1982; 126:131-8. (Pubitemid 13203451)
28. Souza MA. A simple method to purify biologically and antigenically preserved bloodstream trypomastigotes of Trypanosoma cruzi in DEAE-celulose columns. Mem Inst Oswaldo Cruz 1983; 78:317-33.
29. Yoshida N, Mortara RA, Araguth MF, González J, Russo M. Metacyclic neutralizing effect of monoclonal antibody 10D8 directed to the 35 and 50-kilodalton surface glycoconjugates of Trypanosoma cruzi. Infect Immun 1989; 57:1663-7. (Pubitemid 19140124)
30. Nogueira N, Bianco C, Cohn Z. Studies on the selective lysis and purification of Trypanosoma cruzi. J Exp Med 1975; 142:224-9.
31. Krautz GM, Kissinger JC, Krettli AU. The targets of the lytic antibody response against Trypanosoma cruzi. Parasitol Today 2000; 16:31-4, 2000.
32. Ramires MI, Ruiz C, Araya JE, Franco da Silveira JE, Yoshida N. Involvement of the stage-specific 82-kilodalton adhesion molecule of Trypanosoma cruzi metacyclic trypomastigotes in host cell invasion. Infect Immun 1993; 61:3636-41. (Pubitemid 23260031)
33. Plata F, Wietzerbin J, Pons FG, Falcoff E, Eisen H. Synergistic protection by specific antibodies and interferon against infection by Trypanosoma cruziin vitro. Eur J Immunol 1984; 14:930-5. (Pubitemid 14020576)
34. Gutierrez FR, Mineo TW, Pavanelli WR, Guedes PM, Silva JS. The effects of nitric oxide on the immune system during Trypanosoma cruzi infection. Mem Inst Oswaldo Cruz 2009; 104:236-45.
35. Zingales B, Souto RP, Mangia RH, et al. Molecular epidemiology of American trypanosomiasis in Brazil based dimorphisms of rRNA and mini-exon gene sequences. Int J Parasitol 1998; 28:105-12. (Pubitemid 28082063)
36. D'Ávila DA, Macedo AM, Valadares HM, et al. Probing population dynamics of Trypanosoma cruzi during progression of the chronic phase in chagasic patients. J Clin Microbiol 2009; 47:1718-25.
37. Macedo AM, Pimenta JR, Aguiar RS, et al. Usefulness of microsatellite typing in population genetic studies of Trypanosoma cruzi. Mem Inst Oswaldo Cruz 2001; 96:407-13. (Pubitemid 33639497)
38. Nogueira N, Cohn Z. Trypanosoma cruzi: mechanism of entry and intracellular fate in mammalian cells. J Exp Med 1976; 1:1402-20.
39. Brodsky IE, Medzhitov R. Targeting of immune signalling networks by bacterial pathogens. Nat Cell Biol 2009; 11:521-6.
40. Abrahamsohn IA, Coffman RL. Cytokine and nitric oxide regulation of the immunosuppression in Trypanosoma cruzi infection. J Immunol 1995; 155:3955-63.
41. Golden JM, Tarleton RL. Trypanosoma cruzi: cytokine effects on macrophage trypanocidal activity. Exp Parasitol 1991; 72:391-402.
42. Vespa GN, Cunha FQ, Silva JS. Nitric oxide is involved in control of Trypanosoma cruzi-induced parasitemia and directly kills the parasite in vitro. Infect Immun 1994; 62:5177-82. (Pubitemid 24332833)
43. Santiago HC, Geng CG, Báfica A, et al. Mice deficient in LRG-47 display enhanced susceptibility to Trypanosoma cruzi infection associated with defective hemopoiesis and intracellular control of parasite growth. J Immunol 2005; 15:8165-72. (Pubitemid 41798380)
44. Silva JS, Morrissey PJ, Grabstein KH, Mohler KM, Anderson D, Reed SG. Interleukin 10 and interferon gamma regulation of experimental Trypanosoma cruzi infection. J Exp Med 1992; 175:169-74.